p. 84−93
1735-3688
Vol.39/No.2
p. 94−101
1735-3688
Vol.39/No.2
p. 102−106
1735-3688
Vol.39/No.2
p. 107−116
1735-3688
Vol.39/No.2
p. 117−122
1735-3688
Vol.39/No.2
p. 123−129
1735-3688
Vol.39/No.2
p. 130−135
1735-3688
Vol.39/No.2
p. 136−139
1735-3688
Vol.39/No.2
4 ng/ml.The diagnosis of prostate cancer is in an acceptable, but not ideal, stage of the disease; this may be due to screening examinations and tests.]]>
p. 140−143
1735-3688
Vol.39/No.2
p. 144−147
1735-3688
Vol.39/No.2
p. 148−151
1735-3688
Vol.39/No.2
p. 152−153
1735-3688
Vol.39/No.2